Exagen sees FY23 revenue at least $50M, consensus $46.76M

The company said, “For full year 2023 revenue, we are providing guidance of at least $50 million, which will be record annual revenue for the organization. We also believe that our adjusted EBITDA for 2023 will be around negative $20 million, and we expect adjusted EBITDA to improve in 2024.”